|
ETFA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.367030E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.081860E-03 |
| Normal-vs-Stage2 |
8.030600E-01 |
| Normal-vs-Stage3 |
1.83830000000107E-06 |
| Normal-vs-Stage4 |
9.382900E-04 |
| Stage1-vs-Stage2 |
1.077990E-01 |
| Stage1-vs-Stage3 |
4.715900E-02 |
| Stage1-vs-Stage4 |
1.591440E-01 |
| Stage2-vs-Stage3 |
1.492280E-02 |
| Stage2-vs-Stage4 |
2.667700E-02 |
| Stage3-vs-Stage4 |
9.617000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3934999999995E-05 |
| Normal-vs-AfricanAmerican |
1.691540E-02 |
| Normal-vs-Asian |
5.582900E-03 |
| Caucasian-vs-AfricanAmerican |
6.429400E-01 |
| Caucasian-vs-Asian |
6.991600E-01 |
| AfricanAmerican-vs-Asian |
8.800400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.028280E-02 |
| Normal-vs-Female |
1.550580E-04 |
| Male-vs-Female |
7.122400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.040300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.439680E-04 |
| Normal-vs-Age(61-80Yrs) |
3.143800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.372200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.957400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.379800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.750800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.768800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.524600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.163000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.507880E-02 |
| Classical-VS-Follicular |
3.318600E-03 |
| Classical-VS-Other |
8.927000E-01 |
| Classical-VS-Normal |
4.52259999994542E-06 |
| Tall-VS-Follicular |
5.60370000000088E-05 |
| Tall-VS-Other |
5.033000E-01 |
| Tall-VS-Normal |
1.07069999977227E-07 |
| Follicular-VS-Other |
4.597400E-01 |
| Follicular-VS-Normal |
7.979200E-01 |
| Other-VS-Normal |
5.621800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.164800E-03 |
| Normal-vs-N1 |
1.10460000002366E-06 |
| N0-vs-N1 |
3.664600E-03 |
|
|
